Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rockwell Medical (RMTI) Revenue (2016 - 2025)

Historic Revenue for Rockwell Medical (RMTI) over the last 17 years, with Q3 2025 value amounting to $15.9 million.

  • Rockwell Medical's Revenue fell 4375.26% to $15.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $75.6 million, marking a year-over-year decrease of 2359.55%. This contributed to the annual value of $101.5 million for FY2024, which is 2138.09% up from last year.
  • Rockwell Medical's Revenue amounted to $15.9 million in Q3 2025, which was down 4375.26% from $16.1 million recorded in Q2 2025.
  • In the past 5 years, Rockwell Medical's Revenue registered a high of $28.3 million during Q3 2024, and its lowest value of $15.1 million during Q2 2021.
  • For the 5-year period, Rockwell Medical's Revenue averaged around $19.5 million, with its median value being $18.7 million (2022).
  • In the last 5 years, Rockwell Medical's Revenue surged by 4287.61% in 2024 and then plummeted by 4375.26% in 2025.
  • Over the past 5 years, Rockwell Medical's Revenue (Quarter) stood at $15.3 million in 2021, then increased by 25.97% to $19.3 million in 2022, then grew by 14.39% to $22.1 million in 2023, then grew by 11.64% to $24.7 million in 2024, then tumbled by 35.43% to $15.9 million in 2025.
  • Its last three reported values are $15.9 million in Q3 2025, $16.1 million for Q2 2025, and $18.9 million during Q1 2025.